Viewing Study NCT06555068


Ignite Creation Date: 2025-12-24 @ 5:46 PM
Ignite Modification Date: 2025-12-25 @ 3:13 PM
Study NCT ID: NCT06555068
Status: RECRUITING
Last Update Posted: 2025-06-22
First Post: 2024-08-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module